A study on Alzheimer’s disease (AD) showed that apigenin and luteolin can decrease CD40 expression on the surface of microglial cells by investigating the upstream signal transducer and activator of transcription (STAT1) signaling pathway. Here, STAT1 is linked to Alzheimer disease.